Towards Minimally-Invasive Treatment of Brain Damages
In this online seminar, 2020 Ben Barres Spotlight Award winner Mohammad Moeini will discuss his lab’s ongoing research projects in the fields of injectable hydrogels and nanomedicine, both aiming towards the long-term goal of treating the brain damage. The talk will be followed by a Q&A session chaired by eLife Deputy Editor Tim Behrens, which will be dedicated to answering your questions about publishing with e-Life.
Join Tuesday, November 9th at 4:30 pm IRST | 1 pm GMT
The session, which is been organized by Amirkabir University of Technology (Tehran Polytechnic), will last one hour and be run on Adobe Connect.
About the speaker:
Amirkabir University of Technology (Tehran Polytechnic), Iran
Mohammad Moeini is an Assistant Professor of Biomedical Engineering at Amirkabir University of Technology (Tehran Polytechnic) in Iran. He received his Ph.D. in Chemical Engineering from McGill University, followed by postdoctoral training at Polytechnique Montréal and Montreal Heart Institute. Currently, his research is focused on biophotonics, nanomedicine for cancer treatment, and injectable hydrogels for tissue engineering. He was awarded a Ben Barres Spotlight Award in 2020 and has previously published research in eLife on capillary flow and oxygenation in deeper cortical layers.
eLife Deputy Editor
University of Oxford, United Kingdom
Tim Behrens is Professor of Computational Neuroscience at Oxford University and University College London, and a Wellcome Trust Senior Research Fellow. His work investigating the neural mechanisms that control behavior has made an impact across scales from cells to brain regions across mammalian species. He has also developed widely used approaches for measuring brain connections non-invasively that have been taken up by the Human Connectome Project, where he is a senior investigator and chair of the anatomical connectivity team.
In order to attend this online seminar, please register here.